The growing demand for greater accuracy, increased flexibility and reduced errors has prompted biopharmaceutical industry stakeholders to consider shifting from manually operated systems to automated systems for efficient liquid handling Roots Analysis is pleased to announce the publication of its recent study, titled, “Automated Liquid Handling Systems Market, 2023-2035.” The report features an extensive study of the current market landscape, market size and future potential of the liquid handling automation systems market, over the forecast period. It highlights the efforts of various stakeholders engaged in this rapidly emerging segment of the process equipment industry. Key takeaways of the automated liquid handling systems market includes:  An executive summary of the insights captured during our research.  A general overview of liquid handling systems, along with comparison between manual, semi-automated and automated liquid handling systems.  A detailed assessment of

Novel cell cytometry platforms has emerged to be the crucial analytical and visualization tools with applications across various areas, such as immunology, molecular biology, cancer biology and infectious disease monitoring. As a result, developers are currently engaged in the development of technologically advanced cell cytometry platforms that offer better throughput and accuracy. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Cytometer  High Throughput Flow Cytometer  Image Cytometer  Company Size  Very Small  Small  Mid-sized  Large  Very Large  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World Key companies covered in the report  Agilent  Beckman Coulter Life Sciences  Becton Dickinson  Bio-Rad  Chemotec  Milkotronic  Nexcelom Bioscinces  Sartorius  Sony Biotechnology  Thermo Fischer Scie

Novel cell cytometry platforms has emerged to be the crucial analytical and visualization tools with applications across various areas, such as immunology, molecular biology, cancer biology and infectious disease monitoring. As a result, developers are currently engaged in the development of technologically advanced cell cytometry platforms that offer better throughput and accuracy. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Cytometer  High Throughput Flow Cytometer  Image Cytometer  Company Size  Very Small  Small  Mid-sized  Large  Very Large  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World Key companies covered in the report  Agilent  Beckman Coulter Life Sciences  Becton Dickinson  Bio-Rad  Chemotec  Milkotronic  Nexcelom Bioscinces  Sartorius  Sony Biotechnology  Thermo Fischer Scie

Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines The financial opportunity within modular facilities market has been analyzed across the following segments:  Size of Facility  Small Plants  Mid-sized Plants  Large Plants  Very Large Plants  Type of Industry Served  Pharmaceutical  Biotechnology  Type of Modular Construct  Hybrid Skid Modular Constructs  Plug-and-Play Modular Constructs  Skid-Mounted Modular Constructs  Truckable Modular Constructs  Others Modular Constructs  Type of Construction Component  Process Equipment  Base Building  Mechanical, Electrical and Plumbing System  Process Commodities  Other Construction Components  Type of Facility  Manufacturing  Aseptic Filling  Research and Development  Others  Scale

RNA therapies have emerged as a promising treatment modality, with the potential to target and alter genes, modulate protein functions and broaden the range of druggable targets, thereby paving way for new avenues in disease diagnosis and treatment. With rise in government initiatives for early commercialization of pipeline therapies and active involvement of RNA therapeutics investors, we anticipate a variety of novel RNA based therapeutics to be developed, presenting lucrative opportunities for both short- and long-term investors. The financial opportunity within the RNA therapeutics market has been analyzed across the following segments:  Type of Therapy  mRNA Vaccines and Therapeutics  RNAi Therapeutics  RNA Aptamers  Therapeutic Area  Infectious Diseases  Genetic Disorders  Haematological Disorders  Metabolic Disorders  Ocular Disorders  Oncological Disorders  Renal Disorders  Route of Administration  Intradermal  Intramuscular  In

RNA therapies have emerged as a promising treatment modality, with the potential to target and alter genes, modulate protein functions and broaden the range of druggable targets, thereby paving way for new avenues in disease diagnosis and treatment. With rise in government initiatives for early commercialization of pipeline therapies and active involvement of RNA therapeutics investors, we anticipate a variety of novel RNA based therapeutics to be developed, presenting lucrative opportunities for both short- and long-term investors. The financial opportunity within the RNA therapeutics market has been analyzed across the following segments:  Type of Therapy  mRNA Vaccines and Therapeutics  RNAi Therapeutics  RNA Aptamers  Therapeutic Area  Infectious Diseases  Genetic Disorders  Haematological Disorders  Metabolic Disorders  Ocular Disorders  Oncological Disorders  Renal Disorders  Route of Administration  Intradermal  Intramuscular  In

The popularity of 3D printing technology within the dental industry can be attributed to its ability to print high quality / accurate dental products, including crowns, bridges, dentures, dental implants and surgical guides. Driven by the overall growth of the additive manufacturing (3D printing) industry, and wide adoption of 3D printers in the dental sector, the dental 3D printing market is anticipated to witness a steady growth in the foreseen future.

The “Exosome Therapeutics Market, 2022-2040” report features an extensive study on the current market landscape, offering an informed opinion on the likely evolution of the exosome therapies in the treatment of various diseases.